MoviPrep and Ranibizumab ophthalmic
Determining the interaction of MoviPrep and Ranibizumab ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: polyethylene glycol 3350 with electrolytes
Brand name: MoviPrep, Colyte with Flavor Packs, GaviLyte-C, GoLYTELY, NuLYTELY Orange, NuLYTELY with Flavor Packs, PEG-3350 with Electolytes, Plenvu, TriLyte with Flavor Packs, NuLYTELY, TriLyte, Suclear
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- MoviPrep-Ranitidine
- MoviPrep-Ranitidine Capsule
- MoviPrep-Ranitidine Hydrochloride
- MoviPrep-Ranitidine Injection
- MoviPrep-Ranitidine Suspension
- MoviPrep-Ranitidine Syrup
- Ranibizumab ophthalmic-Moxatag
- Ranibizumab ophthalmic-Moxetumomab pasudotox
- Ranibizumab ophthalmic-Moxetumomab Pasudotox-tdfk
- Ranibizumab ophthalmic-Moxetumomab pasudotox-tdfk Intravenous
- Ranibizumab ophthalmic-Moxifloxacin
- Ranibizumab ophthalmic-Moxifloxacin (Systemic)